Literature DB >> 19450099

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK.

Alan Martin1, Suzanne Cottrell, Baudouin Standaert.   

Abstract

OBJECTIVE: To estimate utility scores for different severities of acute rotavirus gastroenteritis in children aged<5 years in the UK.
METHODS: UK general practitioners (n=25) and paediatricians (n=25) rated four different health state descriptions of acute rotavirus gastroenteritis using the EuroQol (EQ-5D) questionnaire for children aged<18 months and 18 months to 5 years. EQ-5D scores were modified to account for limited self-care and mobility, and converted into utility values using the standard algorithm using UK data.
RESULTS: General practitioners rated the mean utility for primary care cases at 0.781 (standard deviation (SD) 0.263) and 0.688 (SD 0.345) for the younger and older age groups, respectively. For hospitalised cases the corresponding scores were 0.425 (SD 0.243) and 0.200 (sd 0.386). Paediatricians rated the mean utility for hospitalised severe cases at 0.595 (SD 0.171) and 0.634 (SD 0.217) in the younger and older groups, respectively, and for hospitalised very severe cases at 0.256 (SD 0.251) and 0.077 (SD 0.340), respectively. In all cases, the utility differences between the health states were statistically significant (p<0.0001).
CONCLUSIONS: Acute rotavirus gastroenteritis substantially impairs quality of life in children aged<5 years as rated by health professionals. This study provides useful quantitative utility estimates for economic evaluations.

Entities:  

Mesh:

Year:  2008        PMID: 19450099     DOI: 10.3111/13696990802321047

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  14 in total

1.  Economic evaluation of routine infant rotavirus immunisation program in Japan.

Authors:  Shu-Ling Hoshi; Masahide Kondo; Ichiro Okubo
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

2.  Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.

Authors:  Fulgence Niyibitegeka; Montarat Thavorncharoensap; Arthorn Riewpaiboon; Sitaporn Youngkong
Journal:  Appl Health Econ Health Policy       Date:  2022-04-26       Impact factor: 3.686

Review 3.  A critical literature review of health economic evaluations of rotavirus vaccination.

Authors:  Samuel Aballéa; Aurélie Millier; Sibilia Quilici; Stuart Caroll; Stavros Petrou; Mondher Toumi
Journal:  Hum Vaccin Immunother       Date:  2013-04-09       Impact factor: 3.452

Review 4.  Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Authors:  Maarten J Postma; Mark Jit; Mark H Rozenbaum; Baudouin Standaert; Hong-Anh Tu; Raymond C W Hutubessy
Journal:  BMC Med       Date:  2011-07-08       Impact factor: 8.775

5.  Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.

Authors:  Mark H Rozenbaum; Marie-Josee J Mangen; Carlo Giaquinto; Jan C Wilschut; Eelko Hak; Maarten J Postma
Journal:  BMC Public Health       Date:  2011-06-10       Impact factor: 3.295

Review 6.  3. How comprehensive can we be in the economic assessment of vaccines?

Authors:  Baudouin Standaert; Rino Rappuoli
Journal:  J Mark Access Health Policy       Date:  2017-08-31

7.  Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes; Douglas Foerster; Rick Aultman
Journal:  Clinicoecon Outcomes Res       Date:  2012-04-20

8.  Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.

Authors:  Joseph T Wu; Mark Jit; Yaming Zheng; Kathy Leung; Weijia Xing; Juan Yang; Qiaohong Liao; Benjamin J Cowling; Bingyi Yang; Eric H Y Lau; Saki Takahashi; Jeremy J Farrar; Bryan T Grenfell; Gabriel M Leung; Hongjie Yu
Journal:  PLoS Med       Date:  2016-03-15       Impact factor: 11.069

9.  The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes
Journal:  Clinicoecon Outcomes Res       Date:  2017-07-17

10.  Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes; Way Seah Lee
Journal:  Clinicoecon Outcomes Res       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.